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Imaging
AbstrAct
Objectives to test the reliability of new ultrasound (US) 
definitions and quantification of synovial hypertrophy (SH) and 
power Doppler (PD) signal, separately and in combination, 
in a range of joints in patients with rheumatoid arthritis (ra) 
using the european league against rheumatisms–Outcomes 
Measures in rheumatology (eUlar-OMeract) combined 
score for PD and SH.
Methods a stepwise approach was used: (1) scoring 
static images of metacarpophalangeal (McP) joints in a 
web-based exercise and subsequently when scanning 
patients; (2) scoring static images of wrist, proximal 
interphalangeal joints, knee and metatarsophalangeal 
joints in a web-based exercise and subsequently 
when scanning patients using different acquisitions 
(standardised vs usual practice). For reliability, kappa 
coefficients (κ) were used.
Results Scoring McP joints in static images showed 
substantial intraobserver variability but good to excellent 
interobserver reliability. in patients, intraobserver 
reliability was the same for the two acquisition methods. 
interobserver reliability for SH (κ=0.87) and PD (κ=0.79) 
and the eUlar-OMeract combined score (κ=0.86) were 
better when using a ‘standardised’ scan. For the other 
joints, the intraobserver reliability was excellent in static 
images for all scores (κ=0.8–0.97) and the interobserver 
reliability marginally lower. When using standardised 
scanning in patients, the intraobserver was good (κ=0.64 
for SH and the eUlar-OMeract combined score, 0.66 
for PD) and the interobserver reliability was also good 
especially for PD (κ range=0.41–0.92).
Conclusion the eUlar-OMeract score demonstrated 
moderate-good reliability in McP joints using a 
standardised scan and is equally applicable in non-McP 
joints. this scoring system should underpin improved 
reliability and consequently the responsiveness of US in ra 
clinical trials.
IntroductIon
Growing data suggest that ultrasound (US) 
is a valuable tool for assessing and classifying 
joint involvement and measuring disease 
activity based on the detection and scoring of 
synovitis in patients with rheumatoid arthritis 
(RA).1 The benefit of US in the evaluation and 
monitoring of patients with RA is mainly based 
on its greater sensitivity in detecting synovitis 
compared with clinical examination.2–4 Colour 
Doppler (CD) and power Doppler (PD) modes 
are able to detect pathological synovial blood 
flow, which reflects the inflammatory activity 
in the joint5–7 and has predictive value in rela-
tion to radiographic progression of structural 
damage8–10 and in relation to disease flare.11–13 
In addition, US-detected synovitis aids more 
Key messages
What is already known about this subject?
 ► no consensus existed until now on a single 
ultrasound  (US) scoring system for rheumatoid 
arthritis (ra) clinical trials.
What does this study add?
 ► a consensus-based US scoring system has been 
validated in multiple joints and has been shown to 
be highly reliable.
How might this impact on clinical practice? 
 ► this highly reliable consensus-based scoring system 
should improve responsiveness and increase the 
uptake of US in ra clinical trials.
group.bmj.com on August 23, 2017 - Published by http://rmdopen.bmj.com/Downloaded from 
2 terslev l, et al. RMD Open 2017;3:e000427. doi:10.1136/rmdopen-2016-000427
RMD Open
accurate early diagnosis of RA to enable earlier treat-
ment.14 15
As RA clinical trials need objective and feasible methods 
for assessing inflammation response and with clinical 
practice focusing on tight control of disease activity, it 
has become imperative to improve the reliability of US 
in quantifying synovitis. Many scoring systems have been 
proposed, however, a recent literature review highlighted 
the lack of an expert-derived consensus.16
The Outcomes Measures in Rheumatology 
(OMERACT) US Working Group in collaboration with 
an US working party of the European League Against 
Rheumatisms (EULAR) conducted a series of US studies 
in order to understand possible reasons for a low agree-
ment in detecting synovitis and to develop and validate 
an expert-derived consensus for scoring synovitis. The 
validation process, outlined in supplementary figure 1 in 
the supplementary online material, was carried out in a 
multistep approach (four steps) from 2005 to 2014. The 
first two steps are described in a companion paper17 in 
which exercises in static images and in clinical setting 
revealed that the causes for the inconsistencies and the 
hampered reliability in scoring synovitis among rheuma-
tologists from different European countries were related 
to several sources of variability such as the perception 
and weighting of the different US components (ie, 
synovial hypertrophy (SH), Doppler activity and also effu-
sion) used for describing and grading the inflammatory 
process17 as well as the differences in the US acquisition 
technique. Based on these discrepancies, the elementary 
components were redefined by Delphi consensus. It was 
agreed: (1) not to include effusion as an inflammatory 
component, as it was considered to be an inconsistent 
finding, frequently detected in healthy subjects or in inac-
tive RA joints;18 19 (2) to redefine synovitis based on SH 
and Doppler only and (3) to score them semiquantita-
tively (0–3) both separately and in combination using the 
novel EULAR-OMERACT combined score.17 These steps 
were performed using metacarpophalangeal (MCP) 
joints as a model.
Having established these basic steps,17 the group 
moved to the second part of the validation process 
which is presented in this paper. The objectives were: 
(1) to evaluate the reliability of the EULAR-OMERACT 
combined score for grading synovitis in MCP joints, as 
well as the definition and quantification of SH and PD 
individually; (2) to test the reliability of a standardised 
consensus-based acquisition method compared with a 
‘usual practice’ scanning method and (3) to evaluate 
the reliability of the new definitions for SH, PD and the 
EULAR-OMERACT combined score in non-MCP joints.
Methods
Twelve US-experienced rheumatologists, who partici-
pated in the first part of the standardisation process,17 
participated in the following steps: (1) testing the validity 
of the new proposed definitions for scoring SH and PD 
separately and in combination (the EULAR-OMERACT 
PDUS score) on static images of MCP joints; (2) applying 
the same definitions and scoring systems in a real-
time patient-based reliability exercise, by comparing a 
consensus-based scanning acquisition method previously 
obtained17 to a ‘usual practice’ scanning method and (3) 
testing the reliability of the new definitions and of the 
EULAR-OMERACT combined score in non-MCP joints 
(wrist, proximal interphalangeal (PIP), knee and meta-
tarsophalangeal (MTP)) in both reading static images 
and scanning patients.
In all the reliability exercises, the participants used 
both a semiquantitative (SQ) (0–3) and a binary score 
(yes/no). The definitions and the scoring systems used 
are presented in table 1.
All patients participating in the reliability exercises 
fulfilled the American College of Rheumatology clas-
sification criteria for RA20 and were attending the 
rheumatology department of Ambroise Paré hospital in 
Boulogne-Billancourt (France).
Patients were selected based on the absence of joint 
deformities and the willingness to take part. The studies 
were conducted in accordance with the Declaration of 
Helsinki and each participant gave written informed 
consent.
step 1. Web-based exercise
A set of high-quality US images of synovitis of MCP joints 
were selected from an anonymised register of patients 
with RA by two independent ultrasonographers (MADA 
and EN) in order to ensure inclusion of a broad range 
of synovitis severity. A random selection of images was 
shown twice in order to assess the intra-reader reliability.
step 2. Patients-based exercise: scanning patients 
according to a different scanning approach
The experts performed a bilateral US scanning of the 
second–fifth MCP joints in eight different patients. 
The dorsal aspect of the joints was examined twice in 
two rounds over 2 days. In the first round, using a ‘stan-
dardised acquisition method’, the US examinations 
were performed using a longitudinal dorsal scan on the 
middle of the joint, first, in GS and then PD, to detect 
joint morphological abnormalities and synovial flow 
respectively. In the second round, a ‘usual practice (free) 
acquisition approach’ of the dorsal side of the MCP joint 
was used. In the standardised scan, the maximal grading 
was to be assessed in the midline. In the ‘usual prac-
tice’ scan method, the examiner recorded the maximal 
grading from any area of the joint.
step 3. testing the new definitions and the reliability of 
the euLAr-oMerAct combined score and of sh and Pd 
individually in non-McP joints
A set of high-quality US images of synovitis of wrist, PIP, 
knees and MTP joints from patients with RA was evalu-
ated using images from the same register and applying 
the same approach as described in step 1.
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After the exercise on static images, the experts 
performed bilateral US scanning of the wrist, PIP,2–5 knee 
and MTP1–5 joints in six different patients twice in two 
rounds over 2 days (first day wrist and PIP joints, second 
day knee and MTP joints), using predefined joint posi-
tions as follows:
 ► Wrist joints (ie, radiocarpal and midcarpal joints 
were evaluated as a single site): palms facing down 
and wrist positioned flat on the examining table, as 
neutral as possible but relaxed; shoulder and elbow 
relaxed; elbow rested on the table. Scanning at the 
level of the radio-lunate joint.
 ► PIP joints: palms facing down and wrist positioned 
flat on the examining table, as neutral as possible 
but relaxed, scanning on the dorsal midline aspect.
 ► Knee joints (ie, suprapatellar and parapatellar 
recesses were scored as a single site): knee 30° 
flexed and scanning on suprapatellar midline 
for the suprapatellar recess; knee extended and 
scanning the parapatellar areas using the retinacula 
as a landmark for the parapatellar medial and lateral 
recesses. Doppler signal was recorded only in the 
medial and lateral parapatellar recesses.
 ► MTP joints: foot placed resting (with knee 30° 
flexed) over its plantar aspect. Scanning recorded 
on the dorsal midline aspect.
For all examinations, identical ESAOTE Technos MPX 
(Genoa, Italy) US machines with an 8–14 MHz linear 
array transducer were used with identical PD settings 
(frequency of 10.1 MHz, pulse repetition frequency of 
750 Hz and Doppler gain of 50–53 dB). Each patient was 
assigned to one machine and the sonographers then 
rotated from one machine to the next in a predefined 
sequence with 10 min allocated for scanning and 
recording the findings on a standard score sheet. Partic-
ipants were blinded to the patients’ clinical details (ie, 
presence or not of active disease).17
stAtIstIcAL AnALysIs
The intraobserver and interobserver reliability of scoring 
static and dynamic images were assessed according 
to weighted Kappa coefficients (κ) relying on abso-
lute differences and in order to take into account the 
magnitude of discrepancy between categories. Intraob-
server coefficients were evaluated on pairs of measures 
performed by the same sonographer at each site, while 
interobserver coefficients were exclusively based on the 
first measure of those pairs. Interobserver reliability 
was studied by calculating the mean κ for all pairs (ie, 
Light’s κ).21 Kappa values were evaluated according to 
Landis and Koch.22 Percentage of observed agreement 
(ie, percentage of observations that obtained the same 
score) and prevalence of the observed lesions were also 
calculated. Statistical analysis was performed using the R 
software (http://www. r- project. org/).
resuLts
step 1. testing the definition and reliability of the EULAr-
OMErAct combined score on static images
Thirty-six images of MCP joints were scored. Table 2 
shows the observed agreement, prevalence and κ values 
results. The agreement was good for the novel definitions 
of synovitis components (SH and PD) both separately 
and in combination (EULAR-OMERACT combined 
score) with the best obtained for PD alone.
Table 1 Definitions of severity grades (0–3) for each elementary component and for the EULAR-OMERACT combined score
Synovitis SH (greyscale)
Doppler
(PD)
Combined score*
(greyscale SH + PD)
Grade 0 (normal) No SH independently of the 
presence of effusion
No Doppler signal No SH and no PD signal
Grade 1 (minimal) Minimal hypoechoic SH* up to 
the level of the horizontal line 
connecting bone surfaces between 
the metacarpal head and the 
proximal phalanx
Up to three single Doppler spots 
OR up to one confluent spot and 
two single spots OR up to two 
confluent spots
Grade 1 hypoechoic SH and ≤ 
grade 1 PD signal
Grade 2 (moderate) Moderate hypoechoic SH† extending 
beyond joint line but with the upper 
surface concave (curved downwards) 
or hypertrophy extending beyond 
the joint line but with the upper 
surface flat
>Grade 1 but <50% Doppler 
signals in the total greyscale 
background
Grade 2 hypoechoic SH and ≤ 
grade 2 PD signal; or grade 1 
SH and a grade 2 PD signal
Grade 3 (severe) Severe hypoechoic SH† with or 
without effusion extending beyond 
the joint line but with the upper 
surface convex (curved upwards)
>Grade 2 (>50% of the total 
greyscale background)
Grade 3 hypoechoic SH and 
≤ grade 3 PD signal; or grade 
1 or 2 SH and a grade 3 PD 
signal
*EULAR-OMERACT combined score.
†Independently of the presence of effusion.
EULAR-OMERACT, European League Against Rheumatisms–Outcomes Measures in Rheumatology; PD, power Doppler; SH, synovial 
hypertrophy.
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Surprisingly, the intraobserver reliability showed a 
great variability between the 12 sonographers for all 
parameters. Similar results were seen for the binary 
score. The interobserver reliability was good to excellent 
for the SQ score of SH, PD and the EULAR-OMERACT 
combined score. For the binary score, the reliability was 
good to excellent for PD and the EULAR-OMERACT 
combined score, but only moderate for SH (table 2). 
When comparing the interobserver reliability for the 
SQ score with the binary score for PD and the EULAR-
OMERACT combined score, reliability showed almost 
identical κ values—the highest κ values were seen for 
the PD score (SQ PD score: κ=0. 98 and binary PD score: 
κ=0.97). For SH, the binary score was considerably lower 
(κ=0.57) than the SQ score (κ=0.78).
step 2. testing the definition and reliability of the euLAr-
oMerAct combined score in patients
No major differences were recorded in the intraobserver 
reliability when scanning in a patient-based exercise 
for the ‘standardised scan’ and ‘usual practice scan’ 
(slightly better for the standardised scan) for all synovitis 
components (SH and PD) and the EULAR-OMERACT 
combined score, and for both binary and SQ grading 
(table 3).
However, interobserver reliability for both SQ and 
binary scores for all components was better when using 
the standardised scan approach (table 4). The κ values 
were good for SQ PD (κ=0.79) but excellent for SH and 
the EULAR-OMERACT combined score (κ=0.87 and 
0.86, respectively). The SQ score performed slightly 
better than the binary score for PD (SQ score: κ=0.79; 
binary κ=0.76) and the EULAR-OMERACT combined 
score (SQ score: κ=0.86; binary κ=0.85).
Only the PD grading for both the binary score and 
the SQ score had better interobserver reliability in static 
images than when scanning patients with a standardised 
scan (tables 2 and 4).
step 3. testing the definition and reliability of the euLAr-
oMerAct combined score in other joints
In the web-based exercise on static images, 100 images 
of wrist, PIP, knee and MTP joints were included repre-
senting a broad range of different degrees of synovitis. 
Table 5 shows the observed agreement, prevalence and 
reliability of the different degrees of SH, PD and the 
EULAR-OMERACT combined score. When scoring static 
images, the intraobserver reliability was good to excellent 
for SH and PD (better for SQ grading than binary) and 
excellent for the EULAR-OMERACT combined P score 
(κ=0.84). The interobserver reliability was good for all 
components (better for binary score than SQ grading) and 
best for PD (binary=0.88 and SQ=0.86). Table 6 shows the 
inter-reader reliability for the synovitis components and 
the EULAR-OMERACT combined score according to the 
different joints. The inter-reader reliability for the EULAR-
OMERACT combined score in the wrist was κ=0.61, for the 
PIPs κ=0.75, for knees κ=0.55 and for the MTPs κ=0.58.
When evaluating the EULAR-OMERACT combined 
score in patients, the intraobserver reliability was good 
with almost identical values for the binary and SQ scores 
for all single components and in combination, ranging 
from 0.64 to 0.66 (table 5). The interobserver reliability 
was moderate to good for all components (0.43–0.61) 
and best for the SQ PD score (0.61) (table 5).
Supplementary figure 2 (online file) shows image 
examples on the EULAR-OMERACT combined score 
applied to PIP, MTP, knee and wrist joints.
Following the results of this multistep project, the 
group agreed on the following procedures for scoring 
synovitis by US: (1) The presence of a hypoechoic SH is 
mandatory for defining the presence of an US-detected 
synovitis and for grading Doppler activity. (2) Grading 
synovitis, at joint level, should be performed by using the 
SQ EULAR-OMERACT score (based on the combined 
presence of both GS SH and Doppler (table 1)).
(3) If different areas of severity are present in the same 
joint, the final severity grade is given by the area with the 
maximum of severity. (4) The acquisition and grading of 
synovitis by US should be performed by using a dorsal 
approach. (5) A standardised scan, with the position of 
the probe in the midline, should be recommended in the 
case of multicentre clinical trials using US, although it 
might underestimate the real inflammatory activity of the 
joint.
dIscussIon
Over the last 10 years, the EULAR-OMERACT US group 
has worked on standardising the US detection, acquisi-
tion and grading of synovitis in patients with RA using a 
stepwise approach. In the first step, the group developed: 
(1) new definitions of the elementary components and a 
novel scoring system based on the grade of severity of SH 
and PD both separately and in combination: the EULAR-
OMERACT combined score; and (2) a standardised 
image acquisition technique.17 In the second part of 
this multistep validation process, the reliability of these 
new definitions and of the scoring system for SH and PD 
separately, and EULAR-OMERACT combined was tested 
in static images, then in patients on MCP and non-MCP 
joints. The participation of the same multinational team 
in every step of the validation process added value to the 
consistency of the results.
The new definitions for grading SH and PD inde-
pendently and combined (EULAR-OMERACT combined 
score) considerably improved the reliability when scoring 
both static images and patients. In these studies, PD was 
chosen as the optimal Doppler modality for the partic-
ular US machines used for depicting inflammation, but 
PD may be substituted by CD in the presented scoring 
system when working with machines where CD is more 
sensitive than PD.23 The interobserver reliability for the 
EULAR-OMERACT combined score in static images was 
good to excellent. In patients, the intraobserver reliability 
of the EULAR-OMERACT combined score showed some 
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variability, probably due to the initial difficulty to apply 
the new definition in ‘real life’ scanning. However, the 
interobserver reliability was good to excellent.
The number of patients involved in the two patient-
based reliability exercises can be seen as a limitation as 
they are in the lower range of the sample sizes usually 
used in imaging studies.24 However, as several joints were 
scanned in each patient (two times 8 joints in the first 
exercise and 22 joints per patient in the second exer-
cise), which in these exercises are seen as independent 
contributors, and as several examiners participated, the 
results can be seen as robust enough for supporting the 
reliability of the scoring.
By using a stepwise process involving discussion and 
agreement, we were able to evaluate the real impact of 
the scanning technique. A standardised approach with 
the probe in a longitudinal plane on the dorsal aspect 
and in the midline of the joint was found to improve the 
reliability as compared with a ‘usual practice’ scanning 
approach. This provides further evidence supporting the 
concept that guidelines for image acquisition are needed 
and that the dorsal aspect of the joint with the probe in 
the midline is recommended to improve reliability when 
assessing small joints25 in multicentre trials though a 
free scan may detect more accurately the real amount of 
inflammation in a joint (as stated in the procedures for 
scanning (3)).
In the first steps of the validation process, the MCP joint 
was used as a model for evaluating the scoring systems. 
However, as the final goal of this process was to produce a 
generalisable instrument to be used in global assessment 
of disease activity, other joint areas were subsequently 
incorporated.26–28 The grading of SH and PD inde-
pendently and the combined EULAR-OMERACT score 
were therefore evaluated in other commonly affected 
joints such as wrist, PIP, knee and MTP joints. Both intra-
reader and inter-reader reliabilities were good in static 
images but lower in patients compared with the reli-
ability in MCP joints and though a standardised scanning 
approach was applied in these joints, further training in 
these joint regions may improve the reliability.
Regarding the US assessment of synovitis, it is important 
to emphasise that although a binary scoring system may 
be more reliable than a SQ grading, it is optimal only in 
monitoring patients for whom synovitis completely disap-
pears during treatment. A binary score does not have the 
sensitivity to detect partial improvement and relies on 
the ability of the treatment to leave no residual inflam-
mation, making it unsuitable for monitoring treatment 
effects in longstanding RA, where a complete disap-
pearance of the SH can be hampered by the copresence 
of osteoarthritis or when complete remission has not 
been obtained. Considering that a number of studies 
have reported the presence of minimal abnormalities 
in both GS and Doppler in healthy controls,18 19 29 the 
development of standardised recommendations for 
scoring synovitis is a major step forward in the develop-
ment of the concept of a minimal detectable US synovitis T
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and defining the threshold of normality. The use of a 
consensus process, based on the analysis of disagreement 
and exploration of factors affecting reliability, represents 
a major advantage of this programme of work. The inclu-
sion of clear definitions of each synovial component and 
the application of a standardised scanning approach has 
ensured a highly robust process.
Though the current study did not address possible 
intermachine variability. This may be a problem in clin-
ical practice best solved by using the best equipment 
giving the patient optimal evaluation.23 In multicentre 
trials, the quality of the machines may be different but 
is almost equivalent as a prerequisite. In addition, the 
patient is examined always with the same equipment and 
same settings minimising the variability.
In our study, the reliability of the EULAR-OMERACT 
combined score was comparable to that of the elementary 
synovitis components. This has important implications in 
multicentre studies as both components can be equally 
reliable in monitoring RA depending on the joint size 
(ie, Doppler mode is less sensitive for deep anatomic 
areas) and the Doppler sensitivity of the US machine.23 
Furthermore, the participation of several sonographers 
from different countries confirms the applicability of the 
proposed scoring system to multicentre clinical trials and 
in daily practice.
In conclusion, using an expert-derived consensus 
process, the EULAR-OMERACT group have developed 
a standardised EULAR-OMERACT combined scoring 
system taking both PD and SH components into account 
in the evaluation of synovitis of multiple RA joints, which 
is highly reliable when applied in scanning patients. The 
reliability was further improved when a standardised 
scanning procedure was used. The application of the 
proposed EULAR-OMERACT combined score and the 
new definition of synovitis based on the presence of SH 
and PD, as well as a standardised scanning approach for 
synovitis in RA, will ensure a greater degree of homoge-
neity and comparability in future US studies and facilitate 
the development of a Global EULAR-OMERACT Syno-
vitis Scoring system at patient level for monitoring RA 
activity in clinical trials and routine care. The group is 
currently working on establishing an optimal reduced 
joint set for scoring synovitis in patients with RA using 
the EULAR-OMERACT combined score.
Author affiliations
1rheumatology department, centre for rheumatology and Spine Diseases, 
rigshospitalet-glostrup, copenhagen, Denmark
2rheumatology and Joint and Bone research Unit, Hospital Universitario Fundacion 
Jimenez Diaz, Madrid, Spain
3Public Health Department, aPHP, Hôpital ambroise Paré, Boulogne-Billancourt; 
inSerM U1173, Versailles-Saint-Quentin University, Montigny le Bretonneaux, 
France
4leeds institute of rheumatic and Musculoskeletal Medicine, University of leeds 
and niHr leeds Musculoskeletal Biomedical research Unit, leeds, UK
5Department of internal Medicine, rheumatology and clinical immunology, Park-
Klinik Weissensee, Berlin, germany
6national institute of rheumatology and Physiotherapy, Budapest, Hungary
7Department of rheumatology, Mc groep Hospitals, lelystad, the netherlands
8rheumatology Unit, Università di torino, torino, italy
9Department of rheumatology, cHrU de Brest, Brest, France
10Medical centre for rheumatology, immanuel Krankenhaus, Buch, Berlin, germany
11Department of rheumatology, Zealand's University Hospital at Kàge, copenaghen, 
Denmark
12clinica reumatologica, Università Politecnica delle Marche, Jesi, ancona, italy
13rheumatology Department, aPHP, ambroise Paré Hospital, Boulogne-Billancourt, 
France
14inSerM U1173, laboratoire d’excellence inFlaMeX, UFr Simone Veil, Versailles-
Saint-Quentin University, Montigny le Bretonneaux, France
Contributors MaDa designed the study. all authors contributed to the acquisition 
of data and have read and revised the manuscript. Pa and MaDa performed all 
statistical analysis and interpretation of data. lt and MaDa drafted the manuscript.
Funding Pgc is supported in part by the national institute for Health research 
(niHr) leeds Musculoskeletal Biomedical research Unit.
Disclaimer the views expressed are those of the author(s) and not necessarily 
those of the nHS, the niHr nor the Department of Health.
Competing interests none declared.
Patient consent Detail has been removed from this case description/these case 
descriptions to ensure anonymity. the editors and reviewers have seen the detailed 
information available and are satisfied that the information backs up the case the 
authors are making.
Provenance and peer review not commissioned; externally peer reviewed.
Data sharing statement there are no unpublished data available.
Open Access this is an Open access article distributed in accordance with the 
creative commons attribution non commercial (cc BY-nc 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. all rights reserved. no commercial use is permitted unless otherwise 
expressly granted.
RefeRences
 1. Colebatch AN, Edwards CJ, Østergaard M, et al. EULAR 
recommendations for the use of imaging of the joints in the 
clinical management of rheumatoid arthritis. Ann Rheum Dis 
2013;72:804–14.
 2. Backhaus M, Burmester GR, Sandrock D, et al. Prospective two 
year follow up study comparing novel and conventional imaging 
procedures in patients with arthritic finger joints. Ann Rheum Dis 
2002;61:895–904.
 3. Wakefield RJ, Green MJ, Marzo-Ortega H, et al. Should oligoarthritis 
be reclassified? ultrasound reveals a high prevalence of subclinical 
disease. Ann Rheum Dis 2004;63:382–5.
 4. Naredo E, Bonilla G, Gamero F, et al. Assessment of inflammatory 
activity in rheumatoid arthritis: a comparative study of clinical 
evaluation with grey scale and power doppler ultrasonography. Ann 
Rheum Dis 2005;64:375–81.
 5. Szkudlarek M, Court-Payen M, Strandberg C, et al. Power 
Doppler ultrasonography for assessment of synovitis in the 
metacarpophalangeal joints of patients with rheumatoid arthritis: 
a comparison with dynamic magnetic resonance imaging. Arthritis 
Rheum 2001;44:2018–23.
 6. Terslev L, Torp-Pedersen S, Savnik A, et al. Doppler ultrasound 
and magnetic resonance imaging of synovial inflammation of the 
hand in rheumatoid arthritis: a comparative study. Arthritis Rheum 
2003;48:2434–41.
 7. Andersen M, Ellegaard K, Hebsgaard JB, et al. Ultrasound colour 
Doppler is associated with synovial pathology in biopsies from hand 
joints in rheumatoid arthritis patients: a cross-sectional study. Ann 
Rheum Dis 2014;73:678–83.
 8. Naredo E, Möller I, Cruz A, et al. Power Doppler ultrasonographic 
monitoring of response to anti-tumor necrosis factor therapy in 
patients with rheumatoid arthritis. Arthritis Rheum 2008;58:2248–56.
 9. Brown AK, Conaghan PG, Karim Z, et al. An explanation for the 
apparent dissociation between clinical remission and continued 
structural deterioration in rheumatoid arthritis. Arthritis Rheum 
2008;58:2958–67.
group.bmj.com on August 23, 2017 - Published by http://rmdopen.bmj.com/Downloaded from 
11terslev l, et al. RMD Open 2017;3:e000427. doi:10.1136/rmdopen-2016-000427
Imaging
 10. Døhn UM, Ejbjerg B, Boonen A, et al. No overall progression and 
occasional repair of erosions despite persistent inflammation in 
adalimumab-treated rheumatoid arthritis patients: results from a 
longitudinal comparative MRI, ultrasonography, CT and radiography 
study. Ann Rheum Dis 2011;70:252–8.
 11. Scirè CA, Montecucco C, Codullo V, et al. Ultrasonographic 
evaluation of joint involvement in early rheumatoid arthritis in 
clinical remission: power doppler signal predicts short-term relapse. 
Rheumatology 2009;48:1092–7.
 12. Saleem B, Brown AK, Quinn M, et al. Can flare be predicted in 
DMARD treated RA patients in remission, and is it important? A 
cohort study. Ann Rheum Dis 2012;71:1316–21.
 13. Foltz V, Gandjbakhch F, Etchepare F, et al. Power Doppler ultrasound, 
but not low-field magnetic resonance imaging, predicts relapse and 
radiographic disease progression in rheumatoid arthritis patients with 
low levels of disease activity. Arthritis Rheum 2012;64:67–76.
 14. Minowa K, Ogasawara M, Murayama G, et al. Predictive grade of 
ultrasound synovitis for diagnosing rheumatoid arthritis in clinical 
practice and the possible difference between patients with and 
without seropositivity. Mod Rheumatol 2016;26:1–6.
 15. Nakagomi D, Ikeda K, Okubo A, et al. Ultrasound can improve the 
accuracy of the 2010 American College of Rheumatology/European 
League against rheumatism classification criteria for rheumatoid 
arthritis to predict the requirement for methotrexate treatment. 
Arthritis Rheum 2013;65:890–8.
 16. Mandl P, Naredo E, Wakefield RJ, et al. A systematic literature review 
analysis of ultrasound joint count and scoring systems to assess 
synovitis in rheumatoid arthritis according to the OMERACT filter. J 
Rheumatol 2011;38:2055–62.
 17. D’Agostino MA, Terslev L, Aegerter P, et al. EULAR-OMERACT 
Ultrasound Taskforce: development of a standardized synovitis 
Scoring System in rheumatoid Arthritis. (accompanying paper) 
Submitted.
 18. Witt M, Mueller F, Nigg A, et al. Relevance of grade 1 gray-scale 
ultrasound findings in wrists and small joints to the assessment 
of subclinical synovitis in rheumatoid arthritis. Arthritis Rheum 
2013;65:1694–701.
 19. Padovano I, Costantino F, Breban M, et al. Prevalence of ultrasound 
synovial inflammatory findings in healthy subjects. Ann Rheum Dis. 
In Press. 2016;75:1819–23.
 20. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism 
Association 1987 revised criteria for the classification of Rheumatoid 
arthritis. Arthritis Rheum 1988;31:315–24.
 21. Light RJ. Measures of response agreement for qualitative 
data: some generalizations and alternatives. Psychol Bull 
1971;76:365–77.
 22. Landis JR, Koch GG. An application of hierarchical kappa-type 
statistics in the assessment of majority agreement among multiple 
observers. Biometrics 1977;33:363–74.
 23. Torp-Pedersen S, Christensen R, Szkudlarek M, et al. Power and 
color Doppler ultrasound settings for inflammatory flow: impact 
on scoring of disease activity in patients with rheumatoid arthritis. 
Arthritis Rheumatol 2015;67:386–95.
 24. Obuchowski NA. How many observers are needed in 
clinical studies of medical imaging? AJR Am J Roentgenol 
2004;182:867–9.
 25. Witt MN, Mueller F, Weinert P, et al. Ultrasound of synovitis in 
rheumatoid arthritis: advantages of the dorsal over the palmar 
approach to finger joints. J Rheumatol 2014;41:422–8.
 26. Backhaus M, Ohrndorf S, Kellner H, et al. Evaluation of a novel 
7-joint ultrasound score in daily rheumatologic practice: a pilot 
project. Arthritis Rheum 2009;61:1194–201.
 27. Naredo E, Rodríguez M, Campos C, et al. Validity, reproducibility, 
and responsiveness of a twelve-joint simplified power doppler 
ultrasonographic assessment of joint inflammation in rheumatoid 
arthritis. Arthritis Rheum 2008;59:515–22.
 28. Perricone C, Ceccarelli F, Modesti M, et al. The 6-joint 
ultrasonographic assessment: a valid, sensitive-to-change 
and feasible method for evaluating joint inflammation in RA. 
Rheumatology 2012;51:866–73.
 29. Millot F, Clavel G, Etchepare F, et al. Investigators of the french early 
Arthritis Cohort ESPOIR. musculoskeletal ultrasonography in healthy 
subjects and ultrasound criteria for early arthritis (the ESPOIR 
cohort). J Rheumatol 2011;38:613–20.
group.bmj.com on August 23, 2017 - Published by http://rmdopen.bmj.com/Downloaded from 
consensus-based scoring system
multiple joints of a standardised 
taskforce-Part 2: reliability and application to
arthritis: a EULAR-OMERACT ultrasound 
Scoring ultrasound synovitis in rheumatoid
G Conaghan, Emilio Filippucci and Maria Antonietta D'Agostino
Sandrine Jousse-Joulin, Wolfgang A Schmidt, Marcin Szkudlarek, Philip
Marina Backhaus, Peter Balint, George A W Bruyn, Annamaria Iagnocco, 
Lene Terslev, Esperanza Naredo, Philippe Aegerter, Richard J Wakefield,
doi: 10.1136/rmdopen-2016-000427
2017 3: RMD Open 
 http://rmdopen.bmj.com/content/3/1/e000427
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://rmdopen.bmj.com/content/3/1/e000427
This article cites 28 articles, 11 of which you can access for free at: 
Open Access
 http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on August 23, 2017 - Published by http://rmdopen.bmj.com/Downloaded from 
